These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 12412676
1. Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O. Eur Respir J; 2002 Oct; 20(4):859-66. PubMed ID: 12412676 [Abstract] [Full Text] [Related]
2. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O. Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782 [Abstract] [Full Text] [Related]
3. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Rabe KF, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Atienza T, Lier PA, Jorup C. Chest; 2006 Feb; 129(2):246-256. PubMed ID: 16478838 [Abstract] [Full Text] [Related]
4. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Atienza T, Aquino T, Fernández M, Boonsawat W, Kawai M, Kudo T, Ekelund J, Ivanov S, Carlsson LG. Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237 [Abstract] [Full Text] [Related]
8. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Lancet; 2006 Aug 26; 368(9537):744-53. PubMed ID: 16935685 [Abstract] [Full Text] [Related]
9. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C. Chest; 2006 Dec 26; 130(6):1733-43. PubMed ID: 17166990 [Abstract] [Full Text] [Related]
15. Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study. O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK. Lancet Respir Med; 2021 Feb 26; 9(2):149-158. PubMed ID: 33010810 [Abstract] [Full Text] [Related]